Ekaterina Royba

Columbia University Irving Medical Center

Papers

2

Total Citations

52

H-Index

2

About

Ekaterina Royba is a leading researcher in radiation biodosimetry, specializing in the development of high-throughput, automated assays for rapid biological dose assessment. Her primary research focuses on the dicentric chromosome assay (DCA), the gold standard for estimating radiation exposure, which she has transformed from a labor-intensive manual process into a fully automated, robotic system. Royba’s major contribution is the creation of the RABiT-II-DCA, a second-generation Rapid Automated Biodosimetry Tool that performs all operations—from sample loading to chromosome scoring—without human intervention, as detailed in her highly cited 2019 paper (42 citations). This breakthrough dramatically increases throughput and reduces operator dependency, making large-scale triage after radiological incidents feasible. She further validated this approach for complex, real-world exposures, such as those from nuclear weapons, in her 2022 work (10 citations). By automating the DCA and proving its robustness under non-standard radiation conditions, Royba has advanced the field toward practical, deployable biodosimetry systems, ensuring faster and more accurate dose estimates for emergency responders and affected populations.

Research Focus

Key Achievements

2
H-Index
2
Papers
52
Total Citations
26
Avg Citations/Paper
🏆 Most Cited Paper
RABiT-II-DCA: A Fully-automated Dicentric Chromosome Assay in Multiwell Plates
42 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Columbia University Irving Medical Center

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago